Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4217422
Max Phase: Preclinical
Molecular Formula: C28H29N9O6
Molecular Weight: 587.60
Molecule Type: Small molecule
Associated Items:
ID: ALA4217422
Max Phase: Preclinical
Molecular Formula: C28H29N9O6
Molecular Weight: 587.60
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCCNC(=O)c2ccccc2C(=O)O)C(=O)O)cc1
Standard InChI: InChI=1S/C28H29N9O6/c1-37(14-16-13-32-23-21(33-16)22(29)35-28(30)36-23)17-10-8-15(9-11-17)24(38)34-20(27(42)43)7-4-12-31-25(39)18-5-2-3-6-19(18)26(40)41/h2-3,5-6,8-11,13,20H,4,7,12,14H2,1H3,(H,31,39)(H,34,38)(H,40,41)(H,42,43)(H4,29,30,32,35,36)/t20-/m0/s1
Standard InChI Key: RUDKDTHAKYAYDC-FQEVSTJZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 587.60 | Molecular Weight (Monoisotopic): 587.2241 | AlogP: 1.31 | #Rotatable Bonds: 12 |
Polar Surface Area: 239.64 | Molecular Species: ACID | HBA: 11 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.11 | CX Basic pKa: 2.75 | CX LogP: 0.86 | CX LogD: -5.57 |
Aromatic Rings: 4 | Heavy Atoms: 43 | QED Weighted: 0.13 | Np Likeness Score: -0.69 |
1. Ravindra M, Wallace-Povirk A, Karim MA, Wilson MR, O'Connor C, White K, Kushner J, Polin L, George C, Hou Z, Matherly LH, Gangjee A.. (2018) Tumor Targeting with Novel Pyridyl 6-Substituted Pyrrolo[2,3- d]Pyrimidine Antifolates via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of De Novo Purine Nucleotide Biosynthesis., 61 (5): [PMID:29425443] [10.1021/acs.jmedchem.7b01708] |
Source(1):